fbpx

World Pharma News

13

Oct2021
NASHVILLE, Tenn., October 12, 2021--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and ... Read More

13

Oct2021
The FDA has approved abemaciclib (Verzenio) in combination with endocrine therapy for the adjuvant treatment of adult patients ... Read More

13

Oct2021
Scientists at Washington University School of Medicine in St. Louis have developed a compound that prevents SARS-CoV-2 and ... Read More

12

Oct2021
PARIS, October 12, 2021--(BUSINESS WIRE)--Regulatory News:GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on ... Read More
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X